Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)

Details for Australian Patent Application No. 2005285035 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Lanter, James C.; Sui, Zhihua

Agent Shelston IP

Pub. Number AU-B-2005285035

PCT Pub. Number WO2006/031715

Priority 60/609,157 10.09.04 US

Filing date 9 September 2005

Wipo publication date 23 March 2006

Acceptance publication date 22 March 2012

International Classifications

C07D 233/34 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4166 (2006.01)

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 5/28 (2006.01) Drugs for disorders of the endocrine system

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/031715 Priority application(s): WO2006/031715

22 March 2012 Application Accepted

  Published as AU-B-2005285035

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005285037-Organosilanes and substrate bonded with same

2005285025-Paint paraphernalia method and apparatus